Back

Recovery of inhibitory control prefrontal cortex function in inpatients with heroin use disorder: a 15-week longitudinal fMRI study

Ceceli, A. O.; Huang, Y.; Gaudreault, P.-O.; McClain, N. E.; King, S. G.; Kronberg, G.; Brackett, A.; Hoberman, G. N.; Gray, J. H.; Garland, E. L.; Alia-Klein, N.; Goldstein, R. Z.

2023-03-29 addiction medicine
10.1101/2023.03.28.23287864 medRxiv
Show abstract

ImportanceHeroin addiction and related mortality impose a devastating toll on society, with little known about the neurobiology of this disease or its treatment. Poor inhibitory control is a common manifestation of prefrontal cortex (PFC) impairments in addiction, and its potential recovery following treatment is largely unknown in heroin (or any drug) addiction. ObjectiveTo study inhibitory control brain activity in iHUD and HC, before and after 15 weeks of inpatient treatment in the former. DesignA longitudinal cohort study (11/2020-03/2022) where iHUD and HC underwent baseline and follow-up fMRI scans. Average follow-up duration: 15 weeks. SettingThe iHUD and HC were recruited from treatment facilities and surrounding neighborhoods, respectively. ParticipantsTwenty-six iHUD [40.6{+/-}10.1 years; 7 (29.2%) women] and 24 age-/sex-matched HC [41.1{+/-}9.9 years; 9 (37.5%) women]. InterventionFollowing the baseline scan, inpatient iHUD continued to participate in a medically-assisted program for an average of 15 weeks (abstinence increased from an initial 183{+/-}236 days by 65{+/-}82 days). The HC were scanned at similar time intervals. Main Outcomes and MeasuresBehavioral performance as measured by the stop-signal response time (SSRT), target detection sensitivity (d, proportion of hits in go vs. false-alarms in stop trials), and brain activity (blood-oxygen level dependent signal differences) during successful vs. failed stops in the stop signal task. ResultsAs we previously reported, at time 1 and as compared to HC, iHUD exhibited similar SSRT but impaired d [t(38.7)=2.37, p=.023], and lower anterior and dorsolateral PFC (aPFC, dlPFC) activity (p<.001). Importantly, at time 2, there were significant gains in aPFC and dlPFC activity in the iHUD (group*session interaction, p=.002); the former significantly correlated with increases in d specifically in iHUD (p=.012). Conclusions and RelevanceCompared to HC, the aPFC and dlPFC impairments in the iHUD at time 1 were normalized at time 2, which was associated with individual differences in improvements in target detection sensitivity. For the first time in any drug addiction, these results indicate a treatment-mediated inhibitory control brain activity recovery. These neurobehavioral results highlight the aPFC and dlPFC as targets for intervention with a potential to enhance self-control recovery in heroin addiction. Key pointsO_ST_ABSQuestionC_ST_ABSDoes inhibitory control brain function, a common impairment in drug addiction, recover with treatment in inpatient individuals with heroin use disorder (iHUD)? FindingsIn this longitudinal cohort study, 26 inpatient iHUD and 24 healthy controls (HC) performed a stop-signal task during functional MRI twice, separated by an average of 15 weeks. In the iHUD, we found lower anterior and dorsolateral prefrontal cortex (comprising the cognitive control network) signaling at baseline, which increased after 15 weeks of treatment, as associated with behavioral improvements. MeaningAs the opioid epidemic continues, our results indicate potential therapeutic targets to enhance neural function underlying self-control in heroin addiction.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
40.0%
2
Addiction Biology
47 papers in training set
Top 0.1%
12.5%
50% of probability mass above
3
Frontiers in Psychiatry
83 papers in training set
Top 0.5%
6.4%
4
Translational Psychiatry
219 papers in training set
Top 1%
4.4%
5
Addiction
25 papers in training set
Top 0.2%
4.2%
6
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.4%
3.6%
7
JAMA Network Open
127 papers in training set
Top 0.9%
3.6%
8
Neuropsychopharmacology
134 papers in training set
Top 1.0%
3.3%
9
International Journal of Drug Policy
11 papers in training set
Top 0.1%
2.5%
10
British Journal of Pharmacology
34 papers in training set
Top 0.2%
1.9%
11
European Journal of Neuroscience
168 papers in training set
Top 0.5%
1.7%
12
Biological Psychiatry
119 papers in training set
Top 2%
1.2%
13
PLOS ONE
4510 papers in training set
Top 62%
1.0%
14
Human Brain Mapping
295 papers in training set
Top 4%
0.9%
15
Brain Sciences
52 papers in training set
Top 2%
0.9%
16
Alcohol
15 papers in training set
Top 0.2%
0.8%
17
Addiction Neuroscience
17 papers in training set
Top 0.4%
0.8%
18
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 1.0%
0.8%
19
The British Journal of Psychiatry
21 papers in training set
Top 1.0%
0.7%
20
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 1%
0.7%
21
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.4%
0.7%
22
Psychopharmacology
59 papers in training set
Top 0.8%
0.5%
23
Cerebral Cortex
357 papers in training set
Top 3%
0.5%
24
Genes, Brain and Behavior
29 papers in training set
Top 0.5%
0.5%